wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38037648-F3138C5F-D35D-413D-8A5B-68FE016ED328
Q38037648-F3138C5F-D35D-413D-8A5B-68FE016ED328
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38037648-F3138C5F-D35D-413D-8A5B-68FE016ED328
Advances in treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: the evolving role of Bcr-Abl mutations and mutational analysis.
P2860
Q38037648-F3138C5F-D35D-413D-8A5B-68FE016ED328
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38037648-F3138C5F-D35D-413D-8A5B-68FE016ED328
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
232680562e3596a7715a14d3d91eb69bc1abd0bd
P2860
Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy.